-+ 0.00%
-+ 0.00%
-+ 0.00%

CRINETICS ANNOUNCES FIRST PATIENT DOSED IN PIVOTAL ADULT TRIAL OF ATUMELNANT IN CONGENITAL ADRENAL HYPERPLASIA (CAH)

Reuters·12/11/2025 21:05:00

Please log in to view news